Elizabeth Trehu Net Worth & Insider Trades

Elizabeth Trehu - Chief Medical Officer, Jounce Therapeutics, Inc

As of February 3, 2022

What is Elizabeth Trehu's Net Worth?

The current estimated net worth of Jounce Therapeutics, Inc's Chief Medical Officer, Elizabeth Trehu, is estimated to be about $768.27K . Elizabeth Trehu owns about 85,202 units of Jounce Therapeutics, Inc common stock. In the last 4 years at Jounce Therapeutics, Inc, Elizabeth Trehu has sold an estimated value of $560.11K worth.

What is Elizabeth Trehu's Past Insider Trading?

Elizabeth Trehu's largest purchase order was 13,500 units , worth over $54.27K on March 31, 2021. Elizabeth Trehu's largest sale order was 13,500 units , worth over $136.21K on March 31, 2021. In total, Elizabeth Trehu has made about 16 transactions over 4 years of their time at Jounce Therapeutics, Inc. Elizabeth Trehu usually trades in February, with the busiest year in 2018. The most recent transaction was a sale order of 8,383 units , worth over $57.7K on January 11, 2022.

Elizabeth Trehu

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Elizabeth Trehu's' Mailing Address?

  • Mailing address is C/o Jounce Therapeutics, Inc. 1030 Massachusetts Avenue Cambridge MA 02138 MA

Jounce Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Richard Murray, Ph.D., 2020 $565,100 $310,810 $491,316 $627,312 $8,946 $2,003,484
Richard Murray, Ph.D., 2019 $540,800 $295,500 $275,044 $348,665 $8,796 $1,468,805
Hugh M. Cole 2020 $420,000 $212,520 $196,500 $250,908 $8,808 $1,088,736
Hugh M. Cole 2019 $401,700 $153,700 $97,900 $124,115 $5,709 $783,124
Kim C. Drapkin 2020 $398,400 $175,300 $174,885 $223,308 $8,688 $980,581
Kim C. Drapkin 2019 $381,200 $145,800 $97,900 $124,115 $8,796 $757,811
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm

What are Jounce Therapeutics, Inc's Past Insider Trades?

Jounce Therapeutics, Inc's most recent insider trade came on January 11, 2022 by Elizabeth Trehu who sold 8,383 units worth $57.7K . In the last 5 years, insiders at Jounce Therapeutics, Inc have sold an estimated value of $42.43M and bought an estimated value of $10.7M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Elizabeth Trehu, Chief Medical Officer,  Kimberlee C Drapkin, CFO and Treasurer,  and Ca Richard Murray, CEO and President .

Jounce Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1